Inhaled corticosteroids form the first choice for preventative treatment of asthma, but they remain expensive for health economies in developing countries. Oral prednisolone is very much cheaper. In this review, we found that, in the management of adults with chronic asthma, a daily dose of prednisolone 7.5 mg/day appears to be equivalent to a moderate to high dose of inhaled steroids (300-2000 mcg/day). Side effects may be present even with low doses of prednisolone, so if there is no alternative to oral steroids, the lowest effective dose should be prescribed. These findings may be use in developing countries where inhaled steroids are not widely available.
Czytaj pełne streszczenie
Wprowadzenie
Steroids are a common treatment of chronic asthma as a maintenance therapy in both developed and developing countries across the world. The cost of inhaled steroids means that in developing countries their availability is limited, leading to poorly controlled asthma in patients who are prescribed low dosage inhaled steroids, or the additional use of oral steroids to control patients' asthma.
This review seeks to determine what dosage of oral steroids equates to the therapeutic effects of a moderate to high doses of inhaled steroids.
Cele
To determine therapeutically equivalent doses of inhaled versus oral steroids for adults with chronic asthma.
Metody wyszukiwania badań
The Cochrane Airways Group trials register was searched and experts in the field were contacted. Searches were current as of August 2008.
Kryteria doboru badań
Randomised controlled trials were selected of at least 4 weeks duration and included patients over the age of 15 years with chronic asthma. Trials compared inhaled steroids and oral prednisolone or prednisone; where the maximum dose for inhaled steroids was 2000 mcg/day and prednisolone 60 mg (on alternate days).
Zbieranie i analiza danych
Two independent reviewers screened 1285 titles and abstracts from the electronic search, bibliography searches and other contacts. Of these, 10 trials met previously defined inclusion criteria. Two reviewers independently extracted study characteristics, and outcome measures.
Główne wyniki
All trials were small and no data could be pooled. Carry-over effects were present in at least one cross-over trial. Data from six trials produced the same pattern, in which prednisolone 7.5-12 mg/day appeared to be as effective as inhaled steroid 300-2000 mcg/day. In two trials, inhaled steroid 300-400 mcg/day was more effective than prednisolone 5 mg/day. All doses of inhaled steroid appeared to be more effective than alternate day doses of prednisolone up to 60 mg on alternate days. Side-effect data were reported too variably to permit comparisons. A 30% incidence was reported in one study in patients receiving prednisolone 5 mg/day, none were reported in patients on inhaled steroids.
Wnioski autorów
A daily dose of prednisolone 7.5-10 mg/day appears to be equivalent to moderate-high dose inhaled corticosteroids. Side-effects may be present on low doses, so if there is no alternative to oral steroids, the lowest effective dose should be prescribed.
